Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12088939.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Serum potassium concentration should be measured immediately before operation to detect hyperkalemia in heart failure patients treated with spironolactone. Renal insufficiency, advanced age, potassium supplementation, decompensated congestive heart failure, and a spironolactone dose larger than 25 mg/d increase the risk of hyperkalemia as a consequence of spironolactone therapy.
Medical subject headings
- Heart Failure
- Hyperkalemia
- Mineralocorticoid Receptor Antagonists
- Renal Insufficiency
- Spironolactone